Beta Bionics, Inc
Price
FilingsNewest: 8-K, Other eventsSep 16 →InsidersNo open-market buys. 8 insiders sold $2.0M, 20 of 34 sales on a 10b5-1 plan.→HoldersEventide 13.9%Soleus 9.8%Morgan Stanley 9.5%→Financing →PeersClosest companies: TECX, XERS, KYMR→
From the filings
Figures
- Revenue
- $119.0Mlast 12 months
- Net income
- −$73.0Mlast 12 months
- Operating cash flow
- −$54.8Mlast 12 months
- Cash and equivalents
- $44.3Mat the last balance sheet
- Shares outstanding
- 45.0M shareson issue